募集资金管理
Search documents
蓝盾光电: 董事会关于2025年半年度募集资金存放与使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-15 08:07
证券代码:300862 证券简称:蓝盾光电 公告编号:2025-041 安徽蓝盾光电子股份有限公司董事会 关于 2025 年半年度募集资金存放与使用情况的 专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 (一)实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于核准安徽蓝盾光电子股份有限 公司首次公开发行股票的批复》(证监许可[2020]1566 号)同意注 册,安徽蓝盾光电子股份有限公司(以下简称"公司"或"蓝盾光电") 首次向社会公众公开发行人民币普通股(A 股)3,297.00 万股,每股 发行价格为人民币 33.95 元,募集资金总额为人民币 111,933.15 万元, 根据有关规定扣除发行费用 4,238.01 万元后,净募集资金共计人民币 容诚会计师事务所(特殊普通合伙)对公司首次公开发行股票的 资金到位情况进行了审验,并于 2020 年 8 月 11 日出具了容诚验字 [2020]230Z0151 号《验资报告》,经其审验,截至 2020 年 8 月 11 日, 扣除券商承销费用和保荐费用后,募集资金 ...
成都圣诺生物科技股份有限公司
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-08-15 03:52
登录新浪财经APP 搜索【信披】查看更多考评等级 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规 划,投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.2重大风险提示 公司已经在本报告中详细阐述公司在生产经营过程中可能面临的各种风险及应对措施,具体请查阅"第 三节 管理层讨论与分析"之"四、风险因素"。敬请投资者予以关注,注意投资风险。 1.3本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性,不存在虚假 记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.1公司简介 公司股票简况 1.4公司全体董事出席董事会会议。 1.5本半年度报告未经审计。 1.6董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 1.7是否存在公司治理特殊安排等重要事项 □适用 √不适用 第二节 公司基本情况 ■ 公司存托凭证简况 □适用 √不适用 联系人和联系方式 ■ 2.2主要财务数据 单位:元 币种:人民币 ■ 2.3前10名股东持股情况表 单位: 股 ■ 2.4前十名境内存托凭证持有人情况表 □适用 ...
安琪酵母股份有限公司
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-08-15 03:48
登录新浪财经APP 搜索【信披】查看更多考评等级 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规 划,投资者应当到http://www.sse.com.cn/网站仔细阅读半年度报告全文。 1.2本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性,不存在虚假 记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 ■ 2.2主要财务数据 1.3董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 第二节 公司基本情况 2.1公司简介 单位:元 币种:人民币 ■ 2.3前10名股东持股情况表 单位: 股 安琪酵母股份有限公司董事会 ■ 2.4截至报告期末的优先股股东总数、前10名优先股股东情况表 □适用 √不适用 2.5控股股东或实际控制人变更情况 □适用 √不适用 2.6在半年度报告批准报出日存续的债券情况 □适用 √不适用 第三节 重要事项 公司应当根据重要性原则,说明报告期内公司经营情况的重大变化,以及报告期内发生的对公司经营情 况有重大影响和预计未来会有重大影响的事项 □适用 √不适用 2025年8月13日 ...
湖南航天环宇通信科技股份有限公司 2025年半年度募集资金存放、 管理与实际使用情况的专项报告
Zheng Quan Ri Bao· 2025-08-14 23:18
根据《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》《上海证券交易所科创 板上市公司自律监管指引第1号——规范运作》的有关规定,湖南航天环宇通信科技股份有限公司(以 下简称"公司"、"本公司")就2025年半年度募集资金存放、管理与使用情况作如下专项报告: 一、 募集资金基本情况 (一)实际募集资金金额、资金到位情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688523 证券简称:航天环宇 公告编号:2025-025 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会于2023年3月30日出具的《关于同意湖南航天环宇通信科技股份有限公司 首次公开发行股票注册的批复》(证监许可[2023]727号),同意公司首次公开发行股票的注册申请, 并经上海证券交易所同意,公司首次向社会公众公开发行人民币普通股(A股)股票40,880,000.00股, 发行价格为每股人民币21.86元,募集资金总额为人民币893,636,800.00元,扣除各项发行费用(不含增 值税)人民币 ...
山东龙大美食股份有限公司关于归还用于暂时补充流动资金的募集资金的公告
Shang Hai Zheng Quan Bao· 2025-08-14 19:34
Core Viewpoint - The company has announced the return of funds used for temporarily supplementing working capital, ensuring compliance with regulations and proper disclosure [1][3]. Group 1 - The company held its fifth board meeting and supervisory board meeting on August 15, 2024, where it approved the use of up to 494.80 million yuan of idle raised funds to temporarily supplement working capital [2]. - The approved amount includes a maximum of 396.00 million yuan from convertible bond idle funds and 98.80 million yuan from non-publicly issued stock idle funds, with a usage period of twelve months from the board's approval date [2]. - As of the announcement date, the company has returned all funds used for temporarily supplementing working capital to the corresponding special account, and the usage period did not exceed twelve months [3].
江苏浩欧博生物医药股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-14 19:32
Group 1 - The company held its 19th meeting of the third supervisory board on August 13, 2025, with all three supervisors present, and the meeting was deemed legal and effective [3] - The supervisory board approved the company's 2025 semi-annual report and its summary, confirming that the report's preparation and review processes complied with relevant laws and regulations [4] - The supervisory board also approved the special report on the storage and actual use of raised funds for the first half of 2025, stating that the management of raised funds adhered to regulatory requirements [6] Group 2 - The company plans to change its auditing firm to Ernst & Young Huaming, as the previous firm, Lixin, has provided services for ten consecutive years [24][32] - The decision to change the auditing firm was based on the need for new auditing services aligned with the company's business development and future audit requirements [32] - The company has communicated with both the outgoing and incoming auditing firms regarding this change, and both parties have no objections [32] Group 3 - The company reported that as of June 30, 2025, it had raised a total of RMB 555.86 million from its initial public offering, with a net amount of RMB 496.47 million after deducting related expenses [12][13] - By June 30, 2025, the company had used RMB 515.85 million of the raised funds for projects and incurred RMB 59.39 million in issuance costs, with a remaining balance of RMB 3.06 million in the raised funds account [13] - The company has implemented strict management of raised funds, ensuring they are stored in dedicated accounts and used for their intended purposes [14] Group 4 - The company has proposed changes to its registered capital and amendments to its articles of association, which were approved during the board meeting on August 13, 2025 [38][39] - The registered capital increased from RMB 630.58 million to RMB 634.80 million following the completion of the stock incentive plan [38] - The amendments to the articles of association will be finalized based on the approval from the relevant registration authority [39] Group 5 - The company announced the convening of its second extraordinary general meeting of 2025, scheduled for September 1, 2025, to discuss various proposals [41][42] - The meeting will utilize a combination of on-site and online voting methods, allowing shareholders to participate remotely [43] - Shareholders must register for the meeting by August 29, 2025, and can delegate representatives to attend [55]
江苏微导纳米科技股份有限公司关于开立募集资金专项账户并签订募集资金专户存储三方监管协议的公告
Shang Hai Zheng Quan Bao· 2025-08-14 19:30
Group 1 - The company has successfully raised a total of RMB 1,170,000,000 through the issuance of convertible bonds, with a net amount of RMB 1,158,921,603.78 after deducting issuance costs [2][3] - The funds have been deposited as of August 12, 2025, and the verification report has been issued by Zhongxinghua Accounting Firm [2][3] - A special account for the management of the raised funds has been established, and a tripartite supervision agreement has been signed to ensure proper usage and storage of the funds [3][4] Group 2 - The tripartite agreement involves the company, the banks where the funds are stored, and the sponsor, CITIC Securities, to regulate the management of the raised funds [4][7] - The special account is exclusively for the company's semiconductor thin film deposition equipment project, and funds cannot be used for other purposes [7][12] - The company is required to notify the sponsor of any cash management products and ensure that these products are not pledged [8][12] Group 3 - The sponsor has the right to conduct ongoing supervision of the fund management and can perform on-site investigations [8][19] - Monthly account statements must be provided by the banks to both the company and the sponsor [20][21] - Any significant withdrawals exceeding 20% of the net raised funds must be reported to the sponsor within two working days [20][21]
北京凯因科技股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-14 19:19
Group 1 - The company held its sixth board meeting on August 14, 2025, with all seven directors present, and the meeting complied with relevant regulations [5][6]. - The board approved the 2025 semi-annual report and summary, confirming that the report accurately reflects the company's financial status and operational results [6][8]. - The board also approved the special report on the storage and use of raised funds, affirming compliance with regulations and proper management of the funds [9][10]. Group 2 - The company raised a total of RMB 805,890,800.00 from its initial public offering, with a net amount of RMB 725,866,140.61 after deducting issuance costs [13][14]. - As of June 30, 2025, the company had utilized RMB 562,780,017.53 of the raised funds, leaving a balance of RMB 187,562,491.34 [15]. - The company has implemented a cash management plan for temporarily idle raised funds, with a balance of RMB 156,900,000.00 as of June 30, 2025 [21][22]. Group 3 - The supervisory board confirmed that the procedures for compiling and reviewing the semi-annual report were in accordance with legal requirements, ensuring the report's accuracy and completeness [27][28]. - The supervisory board also approved the special report on the storage and use of raised funds, affirming that the company adhered to regulations and did not misuse the funds [29][30]. - The supervisory board evaluated the semi-annual assessment report on the quality improvement and efficiency enhancement action plan, confirming its alignment with the company's strategic goals [31][32].
成都圣诺生物科技股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-14 18:34
Group 1 - The core viewpoint of the report is to provide a detailed account of the fundraising activities and the management of raised funds by Chengdu Saintno Biological Technology Co., Ltd. for the first half of 2025 [4][6][26] - The company successfully raised a total of RMB 358 million through the issuance of 20 million shares at a price of RMB 17.90 per share, with a net amount of RMB 285.2 million after deducting issuance costs [4][6] - As of June 30, 2025, the company has utilized RMB 12.57 million of the raised funds for investment projects, with a cumulative usage of RMB 295.9 million [6][8] Group 2 - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and used according to regulatory requirements [7][25] - There were no instances of changing the use of raised funds or using idle funds for temporary liquidity needs during the reporting period [10][13] - The company has a plan to use up to RMB 70 million of temporarily idle self-owned funds for entrusted financial management, aiming to enhance the efficiency of fund usage without affecting daily operations [20][26]
津药达仁堂集团股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-14 18:34
Core Viewpoint - The company has released its 2025 semi-annual report, ensuring the accuracy and completeness of the information provided, and has outlined its financial performance and future plans [1][4][5]. Group 1: Company Overview - The company is known as Tianjin Yao Daren Tang Group Co., Ltd., with the stock code 600329 [4]. - The report is unaudited and emphasizes the importance of reviewing the full semi-annual report for a comprehensive understanding of the company's performance [2][1]. Group 2: Financial Data - The company raised a total of RMB 836.08 million through a non-public offering of shares, with a net amount of RMB 814.34 million after deducting fees [24]. - As of June 30, 2025, the company has utilized RMB 669.88 million for investment projects and has a remaining balance of RMB 57.21 million in its fundraising account [24]. Group 3: Important Resolutions - The board approved the semi-annual report and a special report on the use of raised funds, with unanimous support from all attending directors [7][17]. - A proposal to purchase liability insurance for the company's directors, supervisors, and senior management was also approved, with an insurance limit of up to RMB 100 million [46]. Group 4: Fund Management - The company has established a management method for raised funds to ensure compliance with legal regulations and to protect investor rights [25]. - The company has permanently supplemented its working capital with RMB 150.14 million from surplus raised funds as of June 30, 2025 [37]. Group 5: Compliance and Reporting - The company has adhered to the regulations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding the management and disclosure of raised funds [43].